Troponin I cardiac muscle, Cardiac troponin I, TNNI3, TNNC1, CMH7, RCM1, cTnI, CMD2A, MGC116817.
Sterile Filtered White lyophilized (freeze-dried) powder.
Greater than 95.0% as determined by SDS-PAGE.
TNNI3 Human Chimeric produced in E.Coli is a single, non-glycosylated polypeptide chain (28-110 a.a.) and having a molecular mass of 29072 Dalton.
Troponin I cardiac muscle, Cardiac troponin I, TNNI3, TNNC1, CMH7, RCM1, cTnI, CMD2A, MGC116817.
Cardiac Troponin-I (cTnI) is a critical component of the troponin complex, which plays a pivotal role in the regulation of cardiac muscle contraction. The troponin complex consists of three subunits: Troponin I (cTnI), Troponin T (cTnT), and Troponin C (cTnC). Among these, cTnI is unique to cardiac muscle and serves as a highly specific biomarker for myocardial injury, particularly in the diagnosis of acute myocardial infarction (AMI) .
The development of human recombinant cTnI involves the use of recombinant DNA technology to produce a synthetic version of the protein. This process typically includes the following steps:
The resulting human recombinant cTnI is used in various clinical assays to measure troponin levels in patients’ blood samples, aiding in the diagnosis and management of cardiac conditions .
Human recombinant cTnI is crucial for standardizing clinical assays, ensuring consistency and accuracy across different laboratories and testing platforms. The use of recombinant cTnI helps mitigate the variability observed in traditional assays, which can differ significantly in their sensitivity and specificity .